VALSCIENT Trademark

Trademark Overview


On Tuesday, July 16, 2019, a trademark application was filed for VALSCIENT with the United States Patent and Trademark Office. The USPTO has given the VALSCIENT trademark a serial number of 88516719. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 7, 2022. This trademark is owned by Neurocrine Biosciences, Inc.. The VALSCIENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for diagnosis, prevention and treatment of diseases and disorders by gene therapy, namely, Friedreich's ataxia and congenital birth defects; Pharmaceuticals for the treatment of rare and orphan diseases, disorders and conditions, namely, rare pediatric epilepsies, SCN8A developmental and epileptic encephalopathy, and congenital adrenal hyperplasia; pharmaceutical preparations for the treatment of neurological, central nervous system, psychiatric and movement diseases, disorders and conditions; pharmaceutical preparations for the treatment of endocrine diseases, disorders and conditions; pharmaceutical preparations for the treatment of hormonal diseases, disorders and conditions; pharmaceutical preparations for the treatment of genetic diseases, disorders and conditions
valscient

General Information


Serial Number88516719
Word MarkVALSCIENT
Filing DateTuesday, July 16, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 7, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 12, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for diagnosis, prevention and treatment of diseases and disorders by gene therapy, namely, Friedreich's ataxia and congenital birth defects; Pharmaceuticals for the treatment of rare and orphan diseases, disorders and conditions, namely, rare pediatric epilepsies, SCN8A developmental and epileptic encephalopathy, and congenital adrenal hyperplasia; pharmaceutical preparations for the treatment of neurological, central nervous system, psychiatric and movement diseases, disorders and conditions; pharmaceutical preparations for the treatment of endocrine diseases, disorders and conditions; pharmaceutical preparations for the treatment of hormonal diseases, disorders and conditions; pharmaceutical preparations for the treatment of genetic diseases, disorders and conditions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 22, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Monday, February 7, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 7, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 16, 2021EXTENSION 2 GRANTED
Wednesday, July 7, 2021EXTENSION 2 FILED
Thursday, July 15, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 7, 2021TEAS EXTENSION RECEIVED
Monday, May 24, 2021ASSIGNED TO EXAMINER
Friday, December 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 16, 2020EXTENSION 1 GRANTED
Wednesday, December 16, 2020EXTENSION 1 FILED
Wednesday, December 16, 2020TEAS EXTENSION RECEIVED
Tuesday, July 7, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 12, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 12, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, April 5, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 3, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 7, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 7, 2019NON-FINAL ACTION E-MAILED
Monday, October 7, 2019NON-FINAL ACTION WRITTEN
Wednesday, October 2, 2019ASSIGNED TO EXAMINER
Monday, July 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 19, 2019NEW APPLICATION ENTERED IN TRAM